KRYSTAL BIOTECH INC's ticker is KRYS and the CUSIP is 501147102. A total of 92 filers reported holding KRYSTAL BIOTECH INC in Q1 2020. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2020 | $1,321,000 | -21.9% | 30,544 | 0.0% | 0.02% | +13.3% |
| Q4 2019 | $1,692,000 | +59.5% | 30,544 | 0.0% | 0.02% | +36.4% |
| Q3 2019 | $1,061,000 | -13.7% | 30,544 | 0.0% | 0.01% | -8.3% |
| Q2 2019 | $1,230,000 | +22.4% | 30,544 | 0.0% | 0.01% | +33.3% |
| Q1 2019 | $1,005,000 | +68.3% | 30,544 | +6.3% | 0.01% | +50.0% |
| Q4 2018 | $597,000 | – | 28,723 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Redmile Group, LLC | 2,003,367 | $232,390,572 | 11.06% |
| Frazier Life Sciences Management, L.P. | 988,460 | $114,661,360 | 7.62% |
| S Squared Technology, LLC | 108,215 | $12,552,940 | 6.77% |
| Avoro Capital Advisors LLC | 2,565,555 | $297,604,380 | 4.64% |
| APIS CAPITAL ADVISORS, LLC | 24,000 | $2,784,000 | 3.61% |
| Nicholas Investment Partners, LP | 355,611 | $41,250,876 | 3.08% |
| Ghost Tree Capital, LLC | 80,000 | $9,280,000 | 3.05% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 71,531 | $8,297,596 | 2.52% |
| Affinity Asset Advisors, LLC | 57,500 | $6,670,000 | 1.88% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 46,092 | $5,344,828 | 1.80% |